StarkAge Therapeutics is a privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of life of patients with age-related diseases, associated with senescent cells accumulation.
It builds on its unique disease-specific exosomal / EV technology while harnessing immunotherapy approach, to address very large senescence unmet medical needs.
Company Details
- Employees
- 11
- Founded
- 2018
- Address
- 1, Rue Du Professeur Calmette, Lille,hauts-De-France 59000,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- starklabs.eu
- HQ
- Lille, Hauts-de-France
Starkage Therapeutics Questions
Starkage Therapeutics's website is starklabs.eu
Starkage Therapeutics's LinkedIn profile is https://fr.linkedin.com/company/starkagetherapeutics-anti-ageing
Starkage Therapeutics has
11 employees.
View email and phone details for 11
employees at Starkage Therapeutics.
Starkage Therapeutics's industry is
Biotechnology Research
Starkage Therapeutics's top competitors are
Seekyo Therapeutics,
Innate Pharma,
Genoscreen,
Carla Biotherapeutics,
Apteeus,
Hyprview,
Persea,
See2cure,
Pan Cancer T,
4p-Pharma.
Starkage Therapeutics's categories are Biotechnology Research
Starkage Therapeutics's founding year is 2018
